Surgical Microscopes Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

 The surgical microscopes market size was valued USD 574.34 million in 2017 and is likely to grow at an 11.63% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report. Surgical microscopes are electrically or mechanically operated optical devices that are designed specifically for use in surgical settings for performing microsurgeries. They have lenses that offer illuminated image, stereoscopic vision, and magnification of surgical areas. Surgical microscopes have extensive applications including gynecology, urology, plastic and reconstructive surgery, oncology, dentistry, ENT surgery, ophthalmology, neurosurgery and spine surgery, and others.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7065 

Surgical Microscopes Market Drivers and Restraints

Various factors are adding to the global surgical microscopes market share. These factors, as per the new MRFR report, include customized microscopy solutions, technological advances, advances in healthcare facilities, burgeoning need for MIS, rising number of surgeries, rising use of FIGS (fluorescence image-guided surgery), advancements in the medical sector to develop better surgical approaches, rising number of surgical procedures, and growing demand for surgeries that are minimally invasive. 

On the contrary, the high cost of devices, lack of skilled medical infrastructure, and strict regulatory norms are factors that may limit the surgical microscopes market growth over the forecast period. 

Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the global surgical microscopes market based on end user, application, and type. 

By types, the surgical microscopes market is segmented into ceiling mounted microscopes, table top microscopes, wall mounted microscopes, and on casters microscopes. Of these, on casters microscopes will lead the market over the forecast period for its ease of use. 

By application, the surgical microscopes market is segmented into gynecology, urology, plastic and reconstructive surgery, oncology, dentistry, ENT surgery, ophthalmology, neurosurgery and spine surgery, and others. Of these, neurosurgery and spine surgery will dominate the market over the forecast period, followed by ophthalmology. 

By end users, the surgical microscopes market is segmented into academic & research institutes, physician’s clinics, hospitals, and other outpatient settings. Of these, hospitals will have lions share in the market over the forecast period. Meanwhile, physician’s clinic will grow at the fastest pace over the forecast period for rising cases of ophthalmic surgeries and increasing awareness about dental hygiene and aesthetics.  

Regional Analysis 

Based on the region, the surgical microscopes market report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market over the forecast period. Factors adding to the surgical microscopes market growth in the region include high disposable income, state of the art medical infrastructure, increasing awareness, availability of advanced treatment procedures, and creation of better surgical approaches. Additional factors adding market growth include an increasing number of neurosurgeries, ophthalmic surgeries, & spinal surgeries, and rising awareness about dental hygiene that is increasing dental surgeries and procedures. 

The surgical microscopes market in Europe is predicted to hold the second-largest share over the forecast period for increasing support from the government for device manufacturers, the presence of top market players in the region, and companies’ geographical expansion, which has resulted in a wider reach of medical services and products. 

The surgical microscopes market in the APAC region is predicted to have the fastest growth over the forecast period for increasing number of neurosurgeries in Asian regions, developing medical sector in China & India, rising number of medical device companies, increasing research and development expenditure, and rising government expenditure for the healthcare sector. 

The surgical microscopes market in the MEA is predicted to have the lowest growth over the forecast period.  

Key Players

Eminent players profiled in the global surgical microscopes market report include Topcon Medical Systems, Inc, Takagi Seiko Co. Ltd., Seiler Precision Microscopes, Olympus Corporation, Novartis AG, Leica Microsystems GmbH, Haag-Streit Surgical GmbH, Danaher Corporation, Carl Zeiss AG, Alltion (Wuzhou) Co., Ltd., and Accu-Scope Inc.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-microscopes-market-7065 

Catheter Stabilization Device Market Is Seeing Explosive Growth by Future Industry Winners: Forecast, 2020-2027

 The Global Catheter Stabilization Devices Market is expected to grow at an approximate CAGR of 7.1% during forecast period, 2018–2023. Factors such as growing demand for minimally invasive surgeries; increasing prevalence of lifestyle diseases, such as cardiovascular diseases, cancers; renal failure increase in number of surgeries which may require these devices for postoperative care; and increase in demand to reduce catheter associated complications & infections are expected to drive the market. Growing aging population contributes to increased need of catheter stabilization devices.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6944 

Segmentation:

The Global Catheter Stabilization Devices Market is segmented based on product type, application, end user, and region.On the basis of product type, the market is segmented into Arterial Securement Devices, Central Venous Catheter Securement Devices (further sub segmented into PICC Securement Devices, Subclavian Securement Devices, Midlines Securement Devices, Femoral Securement Devices, Portal Securement Devices, Jugular Securement Devices) Peripheral Securement Devices (further sub segmented into Foley Catheter Securement Devices, Nasogastric Tubes Securement Devices,  Endotracheal Tube Securement Devices, Ventriculoperitoneal Securement Devices, Continuous Nerve Block Catheter Securement Devices) Chest Drainage Tube Securement Devices, Abdominal Drainage Tubes Securement Devices (further sub segmented into Percutaneous Endoscopic Gastrostomy Securement Devices, Jejunal Catheter Securement Devices, Umbilical Catheter Securement Devices)Epidural Securement Devices. Further, on the basis of application the market is segmented into Cardiovascular Procedures, Respiratory Procedures, Gastric and Oropharyngeal Procedures, General Surgery, Urological Procedures, Radiology and Others. End users is segmented into Hospitals & Clinics, Home Healthcare Providers and Diagnostic Centers.

Regional Analysis:

The Global Catheter Stabilization Devices Market is segmented on the basis of regions: Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounted for the major share of the market owing to the huge patient population, well-developed technology, and high healthcare expenditure. Asia Pacific accounted for the second largest market, which is followed by Europe. Asia Pacific is the fastest growing catheter stabilization devices market owing to rapidly changing healthcare sector, huge patient pool in this region, and the presence of vast opportunities for the development of this market. Increasing government support for research & development, well-developed healthcare infrastructure, and presence of geriatric population have driven the European catheter stabilization devices market. However, the Middle East & Africa has the least share in the market owing to the presence of poor and slow developing countries, especially, in African region. The Middle East held the major share of the regional market due to well-developed infrastructure and high spending.

Key players

Some of the key players in the global catheter stabilization market are 3M Company, B. Braun Melsungen Ag, Baxter International, Inc., C. R. Bard, Inc., Centurion Medical Products, Convatec, Inc M.C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, TIDI Products, LLC and others

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/catheter-stabilization-market-6944 

Bioburden Testing Market to Witness Widespread Expansion During 2020-2027

 Global bioburden testing market is witnessing a rapid increase in revenues. The market growth attributes to the rising awareness of the importance of microbial limit testing of pharmaceutical and medical products. Besides, increasing food safety concerns and growing product recalls due to microbial contamination increase the demand for quality control of pharmaceutical products and medical devices.

All medical instruments, raw material, and packaged goods are subject to the microbial contamination risks. Hence, governments actively participate in promoting the use of microbial limits test (MLT) to determine the presence of aerobic bacteria, molds, yeast, and other specific bacteria, such as E. coli, salmonella, and several other harmful microbes.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6716 

Bioburden testing or MLT is based on the pharmacopeia regulatory, which sets standards for medicines and food ingredients. For instance, the United States Pharmacopeia (USP) is an official global standard-setting authority. USP provides strict measures to ascertain that the materials are subjected to optimum pharmaceutical quality assurance to prevent bacterial and fungal contamination.

According to Market Research Future (MRFR), the global bioburden testing market is poised to create a valuation of USD 455 MN, registering over 9.15% CAGR throughout the forecast period (2018–2023). Growing awareness for bioburden testing and developments of a large number of testing kits, act as key tailwinds pushing the market growth. However, there is a vast scope for the development of more MLT tests.

On the flip side, high costs of microbial enumeration instruments and lack of standardization of test reports and certificates are the key factors projected to impede the growth of the market. Also, complicated and time-consuming regulatory policies act as growth barricaders for the bioburden testing market. Nevertheless, increasing RD support and funding from governments for test discoveries would support market growth throughout the predicted period 

Bioburden Testing Global Market – Segments

The is segmented into five dynamics;

By Test Type           : Aerobic Count, Anaerobic Count, Fungi Count, Spore Count, and others.

By Product Type    : Consumables (Reagents & Kits, others), Instruments (Polymerase Chain Reaction Machine, Microscopes, others), and others.  

By Application       : Raw Materials Testing, Medical Devices Testing, In-Process Material Testing, Sterilization Validation Testing, Equipment Cleaning Validation, and others.

By End-User            : Pharmaceutical & Biotechnology Companies, Microbial Testing Laboratories, and others.

By Region               : America, Europe, Asia Pacific, and Rest of the World.

 

Global Bioburden Testing Market – Geographical Analysis

North America dominates the global bioburden testing market. The largest market share attributes to the well-spread awareness for healthcare and the importance of quality control of pharmaceutical and medical products with their microbial limit testing. Besides, the presence of notable key players and well-developed healthcare infrastructure in the region drive the market growth. Moreover, favorable reimbursement scenario in this region fuels the growth of the market.

Also, advances in biotechnology act as a significant tailwind for the market growth. Rising awareness towards the advantages of bioburden testing, alongside augmented governmental spending for R&D to develop novel test kits foster the growth of the market. The North American bioburden testing market is estimated to retain its leading position in the global market throughout the assessment period.

Europe stands second in the global bioburden testing market. The market is predominantly driven by the substantial R&D funds for research invested by the public as well as private sectors. European governments substantially spend on innovations, developing new tests, and improving the existing test kits. The European bioburden testing market is expected to grow pervasively in the years to come, continuing with the same trends.

The Asia pacific bioburden testing market is surging rapidly despite several adversaries. The presence of highly qualified lab professionals and growing numbers of biotechnology companies in India and China predominantly drive the market.  Also, factors such as ongoing programs to increase awareness and developments in healthcare propel the growth of the market. Moreover, the growing rate of literacy and per capita income in the region push market growth. The APAC bioburden testing market is poised to register a modest CAGR over the forecast period. 

Bioburden Testing Market – Competitive Analysis

Although still in its embryonic stage, the bioburden testing market already appears moderately competitive. To gain a larger competitive share, these players incorporate strategies such as mergers & acquisitions, collaboration, expansion, and product launch. Players invest substantially in R&D and trials to develop tests that can give a reading on the microbial limit on pharmaceutical products and medical products for quality control. 

Companies also focus on regions with high unmet needs and require further innovation despite the progress that has been made. This market demonstrates pretty good growth prospects that are expected to attract new entrants, further intensifying the market competition.

Major Players: 

Players leading the global bioburden testing market include Charles River, SGS SA, Wuxi AppTec, Merck KGaA, Becton, Dickinson, and Company, Nelson Laboratories, LLC, North American Science Associates Inc, Pacific Biolabs, ATS Laboratories, Inc., and Dynatec Labs, among others. 

Industry/ Innovations/ Related News 

January 03, 2019 ---- Healthcare Laundry Accreditation Council (HLAC), developers of the HLAC laundry process monitoring toolkit, announced the availability of new process monitoring toolkit – Toolkitâ. The new toolkit validates the effectiveness of a laundry’s processes by measuring the number of microorganisms found in a laundry on hard surfaces, in the air, on linen, in the water, and on the hands of employees. Toolkitâ provides Total Aerobic Microbial Counts (TAMC), Total Yeast & Mold Counts (TYMC), and anaerobic spore-forming bacteria such as Clostridium difficile (C. diff). 

HLAC, a non-profit organization, inspects and accredits laundries processing textiles for hospitals, nursing homes, and other healthcare facilities. HLAC has developed the Laundry Process Monitoring Toolkit to respond to the challenge for operators to know the progress of their processes and whether their standards are on target as initially intended.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/bioburden-testing-market-6716 

New research report offers detailed research on developments in Hemiplegic Migraine Market 2027

 Market Research Future (MRFR) announces the launch of a new release on the global hemiplegic migraine market. The report projects the global hemiplegic migraine market to show a CAGR of 3.3% from 2018 to 2023, growing to a value of USD 1,008 mn by 2023. The market was valued at USD 830 million in 2017.

Hemiplegic migraines are a rare form of migraine and occur in two patterns. One is called familial hemiplegic migraine, which is a hereditary condition that affects at least two close relatives in a family, whereas the other is known as sporadic hemiplegic migraine, as it can occur anywhere. The growing prevalence of sound pollution, air pollution, and growing stress in workplaces have driven the prevalence of hemiplegic migraines over the last few years. As a result, the prevalence of sporadic hemiplegic migraine is much higher than that of familial hemiplegic migraine. Lifestyle factors are likely to take on an ever more important role in the global hemiplegic migraine market’s growth over the forecast period, as hemiplegic migraines are often brought on by environmental factors.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6713 

Growing awareness about migraines and the increasing ease of obtaining migraine medication are likely to be the major drivers for the hemiplegic migraine market over the forecast period. Growing efforts by public healthcare agencies to raise awareness about migraines and the increasing disposable income of consumers around the world have resulted in increased prospects for the global hemiplegic migraine market over the forecast period.

Segmentation:

The global hemiplegic migraine market has been segmented on the basis of type, treatment, preventive treatment, distribution channel, end user, and region.

By type, the market is segmented into familial hemiplegic migraine and sporadic hemiplegic migraine.

By end user, the market is segmented into hospitals & clinics, diagnostic centers, and others.

By treatment, the market is segmented into acute treatment, triptans, ergotamines, NSAIDs, antiemetics, narcotic analgesics, and others.

By preventive treatment, the market is segmented into antidepressants, botox injections, and others.

By distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others.

Regional Analysis:

The global hemiplegic migraine is segmented into the Americas, the Middle East and Africa, Asia Pacific, and Europe. The Americas is likely to be the major regional segment in the global hemiplegic migraine market over the forecast period due to the presence of a large consumer pool and the increasing development of effective treatments for hemiplegic migraine. The strong medical research sector in the U.S. and Canada is likely to be a major driver for the hemiplegic migraine market over the forecast period, along with the increasing disposable income of consumers in emerging Latin American countries such as Mexico, Brazil, Chile, and Argentina.

Europe also holds a leading position in the global hemiplegic migraine market and is likely to hold on to the position over the forecast period due to the widespread awareness about the disease and the increasingly easy availability of hemiplegic migraine medication in Eastern European countries such as the Czech Republic, Austria, Poland, and Slovakia. Western European countries such as the UK, France, Germany, and Spain are mature markets for the healthcare sector and are likely to play a leading role in the market’s development over the forecast period.

Asia Pacific is likely to grow at a rapid growth rate over the forecast period due to the growing potential of the healthcare sector in developing Asia Pacific economies such as China, India, Indonesia, Malaysia, and Singapore. The growing spending capacity of the local consumers is likely to be a key driver for the hemiplegic migraine market in the region over the forecast period, as the region is home to several underdeveloped countries where a majority of the population may not be able to afford hemiplegic migraine medication on a regular basis.

Competitive Analysis:

Leading players in the global hemiplegic migraine market include Abbott Laboratories, AstraZeneca PLC, Endo International PLC, Impax Laboratories, Johnson & Johnson, Merck & Co., Eli Lilly and Company, GlaxoSmithKline PLC, Eisai Co. Ltd., and Allergan PLC.

Industry Updates:

A new case study found in January 2019 that cystic fibrosis may be a risk factor in causing hemiplegic migraine attacks.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hemiplegic-migraine-market-6713 

Nuclear Medicine Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Nuclear Medicine is a branch of medicine which uses radioactive substances in small amounts for diagnosis and treatment of various diseases. Nuclear medicine can be used for the treatment of various conditions including blood disorder, and some cancers and use vastly different imaging technologies than those used in traditional imaging as they show physiological function of the particular system making it a more targeted method of imaging. Market Research Future's report on the global nuclear medicine market divulges a number of vital figures and facts about the market. Nuclear Medicine Market is projected to grow at a CAGR of 13% over the review period. With the rapid expansion of advanced medical technologies, the market is expected to grow at a consistent upward trend to approximate market value of USD 13 Bn by the end of 2027.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6674 

Nuclear medicine offers precise diagnostic abilities and is useful in the early detection of cancer as well as other diseases such as cardiovascular disorders. The increasing prevalence of cancer and other chronic diseases and a high demand for early diagnosis of such diseases for effective treatment is a significant driver of the global market. Moreover, increasingly radiopharmaceuticals are being used for the diagnosis or treatment of chronic diseases in geriatric patients. The rapid expansion of this demographic is expected to encourage the growth of the market. The WHO has recorded astounding figures regarding the prevalence of cancer at nearly one out of every six deaths, making it one of the most significant causes for patient mortality, thus increasing the demand for nuclear medicine.

The promising future of the global nuclear medicine market is threatened by the high costs of radiopharmaceuticals which makes treatment unaffordable. Although it has not been proven to be distinctly harmful, erring on the side of safety has made patients wary of adopting nuclear medicine due to the side effects associated with exposure to radiation. However, market opportunities are expected to mitigate these threats to growth. Radioisotopes are witnessing increased usage for diagnostics and therapeutics as they offer the potential for learning medical information that is otherwise unobtainable. They have a wide range of applications in medical research which range from observing metabolic processes to tracing drug movement in biological systems.

Market Segmentation

MRFR has conducted a detailed study of the various parts of the nuclear medicine market which has been segmented on the basis of product type, application, end-user, and region. By product types, the nuclear medicine market has been segmented into diagnostic nuclear medicine and therapeutic radiopharmaceuticals. At present, the diagnostic nuclear medicine segment has attained a leadership position. However, the therapeutic radiopharmaceuticals segment is the fastest growing segment during the forecast period. The diagnostic nuclear medicine segment is segmented further into SPECT radiopharmaceuticals, and PET radiopharmaceuticals. Meanwhile, the therapeutic radiopharmaceuticals segment is sub-segmented into alpha emitters, beta emitters, and brachytherapy isotopes.

Applications of nuclear medicine are segmented into diagnostic applications and therapeutic applications. Diagnostic applications is a major segment which is sub-segmented into SPECT applications and PET applications. Meanwhile, the therapeutic applications segment is growing at the fastest pace.

End-users have been segmented into hospitals & diagnostic centers, research institutes, and others. Research institutes display the highest potential for growth over the forecast period, while hospitals & diagnostics centers have been identified as the most significant segment in terms of market share.

All sub-segments have been segmented further and included in the report.

Regional Analysis

The Americas due to the presence of North America has established itself as a market leader. The presence of several important market players combined with the high prevalence of cancer and other chronic diseases has influenced the growth of the Americas nuclear market. The region, particularly countries such as U.S & Canada have well-developed healthcare sectors which receive high investments. Moreover, the region has a high geriatric patient population which is expanding rapidly and is growing increasingly aware regarding advanced therapies.

Key Players

Eminent market participants that have been included in MRFR’s report include Jubilant Lifesciences, Lantheus Medical Imaging, Mallinckrodt Pharmaceuticals, Medtronic plc, Bayer AG, Advanced Accelerators Applications, Nordion Inc., Cardinal Health, Bracco Imaging, Curium, and GE Healthcare.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674 

Global Inflammatory Bowel Disease Treatment Market Show Steady Growth: Study 2027

 Market Highlights

The inflammatory bowel disease treatment market is expected to register a CAGR of 2.5% during the forecast period due to the increasing patient pool, advances in medical technology, government initiatives for research on novel drugs discovery, and increasing prevalence of anxiety and depression. Moreover, the increasing number of drugs in clinical trials and the growing popularity of prebiotic and probiotic foods are likely to result in market growth. However, high capital investments required for the discovery of drugs, the unsatisfactory effectiveness of treatments, and stringent drug regulatory policies are restraining the growth of the inflammatory bowel disease treatment market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6266 

Regional Analysis

The Americas is expected to be the largest market for inflammatory bowel disease treatment owing to the increasing prevalence of anxiety and rising incidences of ulcerative colitis and Crohn’s disease. The Centers for Disease Control and Prevention (CDC) has stated that about 1.3% of US adults (3 million) were diagnosed with IBD, either Crohn’s disease or ulcerative colitis, in 2015. Thus, the increasing patient pool will propel market growth during the forecast period. Furthermore, the rising awareness about fitness, presence of key players, and availability of good healthcare infrastructure are likely to fuel the growth of inflammatory bowel disease treatment market.

Europe was the second-largest market for inflammatory bowel disease treatment in 2017 and is expected to register a steady growth rate during the forecast period. This can be attributed to the increasing prevalence of inflammatory bowel disease caused by a rising rate of alcohol abuse in adults, unhealthy lifestyle habits, and prevalence of anxiety and depression in adults. Additionally, factors such as the increasing number of government initiatives and funding for research and development in advanced medical treatment options and the presence of established healthcare infrastructure are likely to propel the growth of the inflammatory bowel disease treatment market in Europe.

 Asia-Pacific is expected to be the fastest-growing inflammatory bowel disease treatment market due to the exponential rise in patient population. The rising number of patients diagnosed with anxiety and depression, the increasing abuse of alcohol, and sedentary lifestyles are expected to result in a greater number of patients afflicted with inflammatory bowel disease, thus driving the demand for treatment. Furthermore, friendly drug-regulatory policies and government initiatives for healthcare reform in the region will propel market growth during the forecast period.

The market in the Middle East & Africa is expected to grow at the slowest rate due to the lack of awareness about the disease, limited access to and availability of treatment facilities, and the prevalence of inflammatory bowel disease.

Segmentation

The global inflammatory bowel disease treatment market has been segmented on the basis of drug class, disease indication, distribution channel, and end-user. Based on drug class, the market has been segmented into TNF inhibitors, aminosalicylates, immunomodulators, and corticosteroids.

By disease indication, the market has been segmented into ulcerative colitis and Crohn’s disease.

Based on distribution channel, the market has been segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

By end-user, the market has been segmented into hospitals and clinics and others.

Based on region, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has been further segmented into North America and South America. The European market has been further divided into Western Europe and Eastern Europe

Key Players

Market Research Future (MRFR) recognizes  Abbott Laboratories, Valeant Pharmaceuticals International, Novartis AG, Janssen Biotech, Inc., Alkem Laboratories Limited, AbbVie, Inc., UCB Inc, Takeda Pharmaceutical Company Limited, Biogen Inc., Pfizer Inc., and Allergan plc as the key players in the global inflammatory bowel disease treatment market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/inflammatory-bowel-disease-treatment-market-6266 

Dissolvable Sutures Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

 Dissolvable sutures are stitches that doctors and surgeons, use to hold skin, internal organs, blood vessels, and all other tissues of the human body together, after the injury, incision, or surgery. These sutures have an anticipated advantage as they are broken down in the body tissue after a given period, and no foreign material is left inside the patient's body.

The global dissolvable sutures market is driven by the growing aging population, increasing incidences of chronic diseases, rising healthcare expenditure, increasing number of surgeries and burns, and rising number of hospitals. In addition, immense technological advancements in material science and increasing occurrences of musculoskeletal diseases are likely to propel the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6081 

Despite the drivers, the development of advanced wound care dressings and availability of alternatives such as surgical staplers and complications such as hemorrhage and leakage especially in esophageal and colonic anastomosis are a few factors restraining the growth of the dissolvable sutures market. Furthermore, stringent government regulations and increasing preference for minimally invasive surgical procedures are the constraints limiting the market growth.

Many prominent players currently dominate the global dissolvable sutures market. For instance, in April 2017 Medtronic Plc signed an agreement to divest a portion of its patient monitoring & recovery division to Cardinal Health for 6.1 USD billion. In this agreement, the company intends to include 17 dedicated manufacturing facilities among the product line such as dental/animal health, chart paper, wound care, incontinence, electrodes, and sharp safety offerings. Moreover, the Surgigut gut sutures by Medtronic are made up of purified connective tissue derived serosal layer of bovine intestines. The other Medtronic dissolvable sutures include VELOSORB fast braided absorbable sutures, CAPROSYN monofilament absorbable suture, and POLYSORB braided absorbable sutures.

In January 2016, Surgical Specialties Corporation acquired FSSB Chirurgische Nadein GMBH, a German manufacturer of surgical needles and sutures. With the acquisition, the company expanded its surgical products portfolio. Further, in September 2015, Smith & Nephew launched NASASTENT Dissolvable Nasal Dressing, a structural intranasal splint for use in sinus surgery.

Regional Analysis

The global dissolvable sutures market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa. North America holds the highest market share in the global dissolvable sutures market owing to the higher adoption of technologically advanced products for surgical procedures in the region, increase in the prevalence of various chronic diseases, and the development of the wound management sector. In addition, according to the Centers for Disease Control and Prevention, in 2015, an approximate 2.8 million people were hospitalized due to injuries in the United States.

Europe holds the second position in the global dissolvable sutures market. The availability of funds for research, increasing healthcare spending, huge patient population, and government support for research and development drive the European market. For instance, according to the National Statistics in 2015, the healthcare spending in the U.K. reached 271.6 USD billion in 2015 from 262.2 USD billion in 2014. Furthermore, the presence of developed countries such as Germany and the U.K. within the region is expected to fuel the market growth during the forecast period.

Asia Pacific is experiencing the fastest growth for the global dissolvable sutures market owing to the increasing prevalence of cardiac diseases, rising obese pool, and geriatric population. India and China dominate the market for dissolvable sutures in the Asia Pacific region. According to World Health Organization, over 1,000,000 people are moderately or severely burnt every year in India. In addition, availability of significant growth opportunities for prominent players due to improved healthcare infrastructure, the rise in healthcare awareness, surge in demand for better healthcare, and developing the medical tourism industry also fuel the growth of the market.

The Middle East and Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities, especially in the African region.

Segmentation

The global dissolvable sutures market is segmented on the basis of type, application, and end-user.

On the basis of type, the market is classified as natural dissolvable sutures and synthetic dissolvable sutures. Natural dissolvable sutures are further segmented as catgut plain sutures and catgut chromic sutures. Synthetic dissolvable sutures are further sub-segmented into polyglycolic acid sutures - coated and braided suture, polyglactin 910 sutures - coated and braided suture, poliglecaprone sutures - monofilament suture, and polydioxanone sutures - monofilament suture.

The global dissolvable sutures market on the basis of application is segmented into cardiovascular surgeries, general surgeries, gynecological surgeries, orthopedic surgeries, ophthalmic surgeries, and others.

On the basis of end-user, the global dissolvable sutures market is segmented into ambulatory surgical centers, hospitals, clinics, and others.

Global Dissolvable Sutures Key Players

1. Braun Melsungen AG, Boston Scientific Corporation, DemeTECH Corporation, ENDOEVOLUTION LLC, Hu-Friedy Mfg. Co., LLC, Internacional Farmacéutica S.A. De C.V., Johnson & Johnson Services, Inc., Medline Industries, Inc., Medtronic, Péters Surgical, Roboz Surgical Instrument Co., Smith & Nephew, Surgical Specialties Corporation, and Sutures India Private Limited are prominent players in the global dissolvable sutures market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dissolvable-sutures-market-6081